Anzeige
Mehr »
Login
Freitag, 03.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
"Special Situation"-Aktie mit Multi-Tenbagger-Potenzial im heißesten Rohstoff-Markt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
176 Leser
Artikel bewerten:
(0)

Philips and American Heart Association Present Fifth Annual Resuscitation Fellowship Award

ANDOVER, Mass., Nov. 12, 2011 /PRNewswire/ -- Royal Philips Electronics (NYSE: PHG, AEX: PHI) today announced that Dr. Carmen Teodorescu, M.D., Ph.D., a post-doctoral fellow at The Heart Institute at Cedars Sinai Medical Center in Los Angeles, California was selected as the recipient of the fifth annual American Heart Association-Philips Resuscitation Fellowship Award.

(Logo: http://photos.prnewswire.com/prnh/20110726/NY41282LOGO )

The $100,000 grant, which is funded over a two-year period by Philips, is intended to encourage young investigators in the early stages of their careers to pursue basic and clinical research related to resuscitation. The American Heart Association-Philips Resuscitation Fellowship Award will allow Dr. Teodorescu to continue her research into the epidemiology of sudden cardiac arrest. Additionally, she will be able to focus on factors associated with ventricular fibrillation and cardiac death syndromes, among other cardiovascular-related subjects.

"Philips is a longtime supporter of the advancement of resuscitation research," said Derek Smith, senior vice president and general manager, Therapeutic Care, Philips Healthcare. "With the AHA fellowship award, it is our honor to support thought leaders in their research that aims to save lives within multiple communities."

Dr. Teodorescu will be presented with the Fellowship Award on November 12, 2011, at the Resuscitation Science Symposium (ReSS) meeting, which is held each year in conjunction with the AHA's Scientific Sessions. This year's meeting will take place in Orlando, Florida, at the Orange County Convention Center.

Philips is a world class leader in emergency care and resuscitation solutions. Philips HeartStart defibrillators are tailored to support the needs of all types of responders, from lay people to professional healthcare providers. Philips defibrillators combine ease-of-use benefits, such as voice instructions and compact design, with clinically proven features for heart rhythm assessment and defibrillation as well as CPR coaching and data management.

About Royal Philips Electronics

Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified health and well-being company, focused on improving people's lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of "sense and simplicity." Headquartered in the Netherlands, Philips employs over 120,000 employees with sales and services in more than 100 countries worldwide. With sales of EUR 22.3 billion in 2010, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in male shaving and grooming, portable entertainment and oral healthcare. News from Philips is located at www.philips.com/newscenter.

SOURCE Royal Philips Electronics

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2011 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.